Recruiting ADHD Studies in Long Beach
P3b Short-term Study of CTN in Patients With ADHD and Comorbid Anxiety
Primary: To evaluate the efficacy of CTN in adults ages with ADHD and comorbid anxiety (AISRS) Key Secondary: To assess the efficacy of CTN in adults ages with ADHD and comorbid anxiety...
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
This study will evaluate the efficacy and safety of SPN-812 (viloxazine extended release) in children 4 to 5 years of age with ADHD....
About ADHD Clinical Trials in Long Beach
Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by inattention, hyperactivity, and impulsivity that interferes with functioning. It affects both children and adults. Treatment includes behavioral therapy, stimulant and non-stimulant medications, and educational support.
There are currently 2 adhd clinical trials recruiting participants in Long Beach, CA. These studies are seeking a combined 594 participants. Research is being sponsored by Otsuka Pharmaceutical Development & Commercialization, Inc., Supernus Pharmaceuticals, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
ADHD Clinical Trials in Long Beach — FAQ
Are there adhd clinical trials in Long Beach?
Yes, there are 2 adhd clinical trials currently recruiting in Long Beach, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Long Beach?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Long Beach research site will contact you about next steps.
Are clinical trials in Long Beach free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Long Beach studies also compensate for your time and travel.
What adhd treatments are being tested?
The 2 active trials in Long Beach are testing new therapies including novel drugs, biologics, and treatment approaches for adhd.
Data updated March 2, 2026 from ClinicalTrials.gov